Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for technology industry professionals · Friday, September 25, 2020 · 526,998,947 Articles · 3+ Million Readers

Global Biopsy Devices Market Trends – Use Of Robot-Assisted Biopsy Systems To Avoid Complications

Biopsy Devices Market Report 2020-30: Growth And Change

Biopsy Devices Global Market Report 2020-30: Growth And Change

The Business Research Company’s Global Biopsy Devices Market Report 2020-30: Growth And Change

LONDON, GREATER LONDON, UK, August 11, 2020 / -- Robot-assisted biopsy systems are shaping the biopsy devices market, and can help avoid complications after the biopsy. A robot-assisted biopsy is done to increase the precision and accuracy of the biopsy process, and medical authorities have been approving the devices to make the process easier.

For instance, in 2019, the FDA (Food and Drug Administration) approved Intuitive Surgical Inc’s Ion Endoluminal Lung Biopsy System, a robot-assisted lung biopsy device that uses an ultra-thin articulating robotic catheter. The robotic catheter has an outer diameter of 3.5 mm so that physicians can navigate through thin and tortuous airways and can move 180 degrees in all directions. The system is equipped with a flexible biopsy needle that can pass through tight bends so that it can collect tissue in peripheral lung.

The global biopsy devices market size is expected to decline from $2.42 billion in 2019 to $2.32 billion in 2020 at a compound annual growth rate (CAGR) of -4.45%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, especially postponement of non-emergency procedures. The biopsy devices market is then expected to recover and reach $3.05 billion in 2023 at a CAGR of 9.6%.
The rise in the number of cancer cases contributed to the growth of the biopsy devices market.

A biopsy is a primary approach used by doctors to diagnose any abnormalities in the bodies if the presence of cancer cells is suspected. In 2018, according to the World Health Organization, around 2.09 million cases of lung cancer, 1.28 million prostate cancer cases, and 1.03 million stomach cancer cases were diagnosed. The increase in the diagnosis of cancer through biopsy increased the demand for biopsy devices and thereby drove the market.

The rise in complications associated with biopsies is expected to limit the biopsy devices market growth. Complications resulted from a biopsy include excessive bleeding, infection, puncture damage to nearby organ tissue, and skin numbness around the biopsy site. In some cases, not enough materials are collected and the process needs to be repeated. According to research published in January 2020, major bleeding after percutaneous native kidney biopsy was around 4.3%. These complications in biopsy procedures impact the biopsy devices market’s growth.

The biopsy devices market consists of sales of biopsy devices and related services by entities (organizations, sole traders and partnerships) that manufacture biopsy devices. Biopsy devices are used to extract sample cells or tissues from the patient’s body to be examined to determine the presence of a disease.

The biopsy devices market is segmented by product type into needle-based biopsy instruments, core biopsy devices, aspiration biopsy needles, vacuum-assisted biopsy devices, biopsy forceps, and localization wires. By imaging technology, the market is segmented into MRI-guided biopsy, stereotactic-guided biopsy, ultrasound-guided biopsy, and CT scan.

Here Is A List Of Similar Reports From The Business Research Company

Liquid Biopsy Market Global Report 2020 (

Computed Tomography (CT) Scanners Devices And Equipment Global Market Report 2020 (

Interested to know more about The Business Research Company?

The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
email us here
Visit us on social media:

Powered by EIN Presswire

EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release